Sai Sreyas Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 8.00 Cr
as on 17-07-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 29.75 Cr
as on 17-07-2024
- Revenue 7350.52%
(FY 2023)
- Profit -189.83%
(FY 2023)
- Ebitda 1658.44%
(FY 2023)
- Net Worth 113.12%
(FY 2023)
- Total Assets 50.52%
(FY 2023)
About Sai Sreyas Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.00 Cr.
The company currently has active open charges totaling ₹29.75 Cr.
Dileep Bakireddy, Saraswathi Bakireddy, Devereddy Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC068382
- Company No.
068382
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sai Sreyas Pharmaceutical?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dileep Bakireddy  | Director | 21-Jan-2021 | Current |
| Saraswathi Bakireddy | Director | 19-Jun-2019 | Current |
| Devereddy Reddy | Director | 15-Dec-2011 | Current |
| Bakireddy Reddy | Director | 17-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Sai Sreyas Pharmaceutical.
Sai Sreyas Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 7350.52% increase. The company also saw a substantial fall in profitability, with a 189.83% decrease in profit. The company's net worth Soared by an impressive increase of 113.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Sreyas Pharmaceutical?
In 2023, Sai Sreyas Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Primoris Systems India Private Limited
Active
9 years 5 months Saraswathi Bakireddy and Bakireddy Reddy are mutual person
Corey Organics Private Limited
Active 28 years 7 months Dileep Bakireddy and Devereddy Reddy are mutual person
Advantage One Human Resourcing Private Limited
Active 16 years 3 months Saraswathi Bakireddy and Bakireddy Reddy are mutual person
Sri Chavadi Pharma Private Limited
Active 28 years 8 months Dileep Bakireddy and Devereddy Reddy are mutual person
Sjd Developers Private Limited
Active 10 years 2 months Dileep Bakireddy, Saraswathi Bakireddy and 2 more are mutual person
Hexaforce Solutions Llp
Active 7 years 9 months Saraswathi Bakireddy and Bakireddy Reddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 09 Aug 2021 | ₹29.75 Cr | Open |
How Many Employees Work at Sai Sreyas Pharmaceutical?
Sai Sreyas Pharmaceutical has a workforce of 66 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jan 13, 2023, Sai Sreyas Pharmaceutical has raised a total of ₹ 18.37 Cr, with the most recent deal valued at ₹ 1.23 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
